Epigenetic biomarkers: A new perspective in laboratory diagnostics

Epigenetics comprises the study of chemical modifications in the DNA and histones that regulates the gene expression or cellular phenotype. However, during the last decade this term has evolved after the elucidation of different mechanisms (microRNAs and nuclear organization of the chromosomes) invo...

Full description

Saved in:
Bibliographic Details
Published inClinica chimica acta Vol. 413; no. 19-20; pp. 1576 - 1582
Main Authors García-Giménez, J.L., Sanchis-Gomar, F., Lippi, G., Mena, S., Ivars, D., Gomez-Cabrera, M.C., Viña, J., Pallardó, F.V.
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 09.10.2012
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Epigenetics comprises the study of chemical modifications in the DNA and histones that regulates the gene expression or cellular phenotype. However, during the last decade this term has evolved after the elucidation of different mechanisms (microRNAs and nuclear organization of the chromosomes) involved in regulating gene expression. Epigenetics and the new designed technologies capable to analyze epigenetic changes (e.g., methylated DNA, miRNAs expression, post-translational modifications on histones among others) have disclosed an appealing scenario that will offer for the biomedical sciences new biomarkers for the study of neurodegenerative diseases, multifactorial complex diseases, rare diseases and cancer. Moreover, new technologies adapted for epigenetic studies will offer promising applications that in the next years will be common technologies in clinical laboratories. In this review we discuss epigenetic modifications used as possible biomarkers in several diseases. We also present the potential of methodologies to purify histones, and high throughput technologies as candidates to be set in clinical laboratories for their high potential analyzing epigenetic processes. ► We discuss some new technologies and recent applications of epigenetics. ► These new technologies will allow us to discover epigenetic biomarkers. ► Epigenetic biomarkers exhibit good sensitivity and reproducibility. ► They will also help to identify or classify diseases or the efficacy of a drug.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:0009-8981
1873-3492
DOI:10.1016/j.cca.2012.05.021